Filing Details
- Accession Number:
- 0000886163-15-000072
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-06-30 17:39:18
- Reporting Period:
- 2015-06-26
- Filing Date:
- 2015-06-30
- Accepted Time:
- 2015-06-30 17:39:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 886163 | Ligand Pharmaceuticals Inc | LGND | Pharmaceutical Preparations (2834) | 770160744 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1237556 | W Matthew Foehr | 11119 North Torrey Pines Road, Suite 200 La Jolla CA 92037 | President And Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-06-26 | 12,500 | $9.97 | 82,628 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-06-26 | 12,500 | $100.97 | 70,128 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2015-06-29 | 2,500 | $9.97 | 72,628 | No | 4 | M | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2015-06-26 | 12,500 | $0.00 | 12,500 | $9.97 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2015-06-29 | 2,500 | $0.00 | 2,500 | $9.97 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 94,510 | 2021-04-18 | No | 4 | M | Direct | |
| 92,010 | 2021-04-18 | No | 4 | M | Direct |
Footnotes
- The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on May 20, 2015, in accordance with Rule 10b5-1.
- Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 04/18/11.
Billionaire Hedge Funds
